Evidence map›Paper›PMID 16909382›Full record

ArticleAmerican journal of human genetics2006

A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon.

Klaus Fellermann, Daniel E Stange, Elke Schaeffeler, Hartmut Schmalzl, Jan Wehkamp, Charles L Bevins, Walter Reinisch, Alexander Teml, Matthias Schwab, Peter Lichter and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 209 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
209citing papers in PubMed, 1 pooled it
22.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

209 citing papers in PubMed, 1 synthesis or guideline pooled it, 561 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. The epithelium takes the stage in asthma and inflammatory bowel diseases.Frontiers in cell and developmental biology · 2024
    Review
  12. Article
  13. Mechanisms and regulation of defensins in host defense.Signal transduction and targeted therapy · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

149 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Klaus FellermannDepartment of Internal Medicine I, Robert-Bosch-Hospital, 70376 Stuttgart, Germany. klaus.fellermann@rbk.de
Daniel E Stange
Elke Schaeffeler
Hartmut Schmalzl
Jan Wehkamp
Charles L Bevins
Walter Reinisch
Alexander Teml
Matthias Schwab
Peter Lichter
Bernhard Radlwimmer
Eduard F Stange
Robert Bosch Hospital · DEHeidelberg University · DEMedical University of Vienna · ATUniversity of California, Davis · USGerman Cancer Research Center · DE

Funding

Novel Defensins in Human Epithelial TissuesR37AI032738 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BEVINS, CHARLES L · 2015 to 2022
$3.1M
Novel Defensins of Human EpitheliaR01AI032738 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BEVINS, CHARLES L · 1993 to 2009
$2.3M
NIAID NIH HHS AI32738NIAID NIH HHS R01 AI032738NIAID NIH HHS R37 AI032738
6 · The paper itself

Abstract

Defensins are endogenous antimicrobial peptides that protect the intestinal mucosa against bacterial invasion. It has been suggested that deficient defensin expression may underlie the chronic inflammation of Crohn disease (CD). The DNA copy number of the beta-defensin gene cluster on chromosome 8p23.1 is highly polymorphic within the healthy population, which suggests that the defective beta-defensin induction in colonic CD could be due to low beta-defensin-gene copy number. Here, we tested this hypothesis, using genomewide DNA copy number profiling by array-based comparative genomic hybridization and quantitative polymerase-chain-reaction analysis of the human beta-defensin 2 (HBD-2) gene. We showed that healthy individuals, as well as patients with ulcerative colitis, have a median of 4 (range 2-10) HBD-2 gene copies per genome. In a surgical cohort with ileal or colonic CD and in a second large cohort with inflammatory bowel diseases, those with ileal resections/disease exhibited a normal median HBD-2 copy number of 4, whereas those with colonic CD had a median of only 3 copies per genome (P=.008 for the surgical cohort; P=.032 for the second cohort). Overall, the copy number distribution in colonic CD was shifted to lower numbers compared with controls (P=.002 for both the surgical cohort and the cohort with inflammatory bowel diseases). Individuals with < or = 3 copies have a significantly higher risk of developing colonic CD than did individuals with > or = 4 copies (odds ratio 3.06; 95% confidence interval 1.46-6.45). An HBD-2 gene copy number of < 4 was associated with diminished mucosal HBD-2 mRNA expression (P=.033). In conclusion, a lower HBD-2 gene copy number in the beta-defensin locus predisposes to colonic CD, most likely through diminished beta-defensin expression.

Indexed as

Gene DosageGenetic Predisposition to Diseasebeta-DefensinsChromosomes, Human, Pair 8ColonCrohn DiseaseDNA Mutational AnalysisGene ExpressionHumansInflammatory Bowel DiseasesMultigene FamilyOligonucleotide Array Sequence AnalysisPolymorphism, Geneticbeta-DefensinsDEFB4A protein, human

Identifiers

PMID16909382
PMCPMC1559531
OpenAlexW2116034738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.